<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/D5337A10-AC8A-402A-8164-C5F9CC6B0140"><gtr:id>D5337A10-AC8A-402A-8164-C5F9CC6B0140</gtr:id><gtr:name>Queen Mary, University of London</gtr:name><gtr:address><gtr:line1>Mile End Road</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>E1 4NS</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/99A20F70-F6B7-43DE-94E4-7004FAE6291E"><gtr:id>99A20F70-F6B7-43DE-94E4-7004FAE6291E</gtr:id><gtr:name>Ludwig Maximilians University Munich</gtr:name><gtr:address><gtr:line1>Geschwister-Scholl-Platz 1</gtr:line1><gtr:postCode>D-80539</gtr:postCode><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/FEF0A749-B120-4F09-B8E8-01CFCDFC0A2F"><gtr:id>FEF0A749-B120-4F09-B8E8-01CFCDFC0A2F</gtr:id><gtr:name>Baylor College of Medicine</gtr:name><gtr:address><gtr:line1>Baylor College of Medicine</gtr:line1><gtr:line2>Texas Medical Center</gtr:line2><gtr:line4>Houston</gtr:line4><gtr:line5>Texas</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/1E3015FF-23BB-4B73-8C80-84C53F33B745"><gtr:id>1E3015FF-23BB-4B73-8C80-84C53F33B745</gtr:id><gtr:name>Hospital for Sick Children, Toronto</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/0F15002C-C70C-4AD9-B432-E950F6B2FDFD"><gtr:id>0F15002C-C70C-4AD9-B432-E950F6B2FDFD</gtr:id><gtr:name>European Institute of Oncology</gtr:name><gtr:address><gtr:line1>Via Ripamonti 435</gtr:line1><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/D5337A10-AC8A-402A-8164-C5F9CC6B0140"><gtr:id>D5337A10-AC8A-402A-8164-C5F9CC6B0140</gtr:id><gtr:name>Queen Mary, University of London</gtr:name><gtr:department>Blizard Institute of Cell and Molecular</gtr:department><gtr:address><gtr:line1>Mile End Road</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>E1 4NS</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/D5337A10-AC8A-402A-8164-C5F9CC6B0140"><gtr:id>D5337A10-AC8A-402A-8164-C5F9CC6B0140</gtr:id><gtr:name>Queen Mary, University of London</gtr:name><gtr:address><gtr:line1>Mile End Road</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>E1 4NS</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/99A20F70-F6B7-43DE-94E4-7004FAE6291E"><gtr:id>99A20F70-F6B7-43DE-94E4-7004FAE6291E</gtr:id><gtr:name>Ludwig Maximilians University Munich</gtr:name><gtr:address><gtr:line1>Geschwister-Scholl-Platz 1</gtr:line1><gtr:postCode>D-80539</gtr:postCode><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/FEF0A749-B120-4F09-B8E8-01CFCDFC0A2F"><gtr:id>FEF0A749-B120-4F09-B8E8-01CFCDFC0A2F</gtr:id><gtr:name>Baylor College of Medicine</gtr:name><gtr:address><gtr:line1>Baylor College of Medicine</gtr:line1><gtr:line2>Texas Medical Center</gtr:line2><gtr:line4>Houston</gtr:line4><gtr:line5>Texas</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/1E3015FF-23BB-4B73-8C80-84C53F33B745"><gtr:id>1E3015FF-23BB-4B73-8C80-84C53F33B745</gtr:id><gtr:name>Hospital for Sick Children, Toronto</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/0F15002C-C70C-4AD9-B432-E950F6B2FDFD"><gtr:id>0F15002C-C70C-4AD9-B432-E950F6B2FDFD</gtr:id><gtr:name>European Institute of Oncology</gtr:name><gtr:address><gtr:line1>Via Ripamonti 435</gtr:line1><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/30F3733B-EF3F-49A6-AA58-8AF9E640A3F3"><gtr:id>30F3733B-EF3F-49A6-AA58-8AF9E640A3F3</gtr:id><gtr:firstName>Ashirwad</gtr:firstName><gtr:surname>Merve</gtr:surname><gtr:roles><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0902001"><gtr:id>163B76DB-1662-454C-881A-3E204195C0CE</gtr:id><gtr:title>The Bmi1/BMP connection in medulloblastoma pathogenesis</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Fellowship</gtr:grantCategory><gtr:grantReference>G0902001</gtr:grantReference><gtr:abstractText>Medulloblastoma are the commonest brain cancers seen in young children. They have a poor survival rate despite improvements in some of the current treatment methods. We have recently shown that a gene called Bmi1 is strongly expressed in a significant proportion of these tumours. We now want to understand more in detail how this gene might control the growth of medulloblastoma. Especially we want to test the hypothesis that the expression of Bmi1 identifies a group of medulloblastoma which could be sensitive to treatment with molecules called BMPs. 
There are studies in mouse models which show that BMPs inhibit growth of medulloblastoma. We want to assess whether this holds true also in cells derived from human tumours grown into recipient mice (xenograft). 
We also aim to test if regulation of BMP by Bmi1 might affect the way cells interact with each other. This could enable us to understand how medulloblastoma spread and infiltrate the surrounding brain and distant organs.</gtr:abstractText><gtr:technicalSummary>Medulloblastoma are the most common malignant brain tumours of childhood and they are still associated with high morbidity and mortality. The PcG gene Bmi1 is overexpressed in a significant proportion of human medulloblastoma and it induces and maintains tumour growth in several model systems. Our unpublished data in medulloblastoma cell lines show that repression of BMP signalling pathway through Bmi1 is a crucial pathogenetic event in medulloblastoma, which leads to deregulation of cell adhesion and of cell-extra cellular matrix interactions. 

Aims and Objectives: 
To elucidate the contribution to tumour growth of Bmi1 mediated repression of BMP pathway in a xenograft model of human medulloblastoma and in a genetically engineered mouse model. To provide proof of principle that Bmi1 expression identifies medulloblastoma, the growth of which can be counteracted by BMP treatment in a xenograft model. 

Design and Methodology: 
Human primary medulloblastoma cells : 
Human primary medulloblastoma cells will be obtained from the Paediatric Brain Tumour Xenograft Consortium and will be screened for Bmi1 expression. Bmi1 will be downregulated with shRNA and BMP pathway upregulation will be validated. Furthermore, functional assays to study effects on cell adhesion properties in relation to Bmi1 expression profile will be performed. The candidate genes controlled by Bmi1 through BMP pathway repression will be identified and validated in tissue microarrays of human medulloblastoma. 

Xenograft model: 
Xenografts will be generated in NOD/SCID mice by intracerebellar injection of selected human primary medulloblastoma cell lines upon Bmi1 knock down and tumour growth will be monitored as compared to control xenografts. Xenografts will also be established from human primary medulloblastoma cell lines either overexpressing Bmi1 or with basal level of Bmi1 expression upon treatment with BMPs. Analysis of incidence, latency, biological behaviour and histological characteristics of the tumours will be performed. 

Genetically engineered mouse model: 
Bmi1 deficiency has been shown to impair medulloblastoma development in a mouse model - NeuroD2Smo*A1;Bmi1-/-. We will use this model to analyse the contribution of Bmi1 mediated repression of the BMP pathway and deregulation of cell adhesion to medulloblastoma growth. 

Scientific and medical opportunities: 
The current medulloblastoma treatment is based on non specific antiproliferative
therapies which do not take into account the specific, often unknown, mechanism driving tumour
growth in each tumour subgroup. The characterisation of the role of Bmi1/BMP in medulloblastoma pathogenesis will have implications for risk stratification of patients and for development of more targeted and less toxic therapeutic strategies for these neoplasms.</gtr:technicalSummary><gtr:fund><gtr:end>2013-10-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2010-11-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>266500</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Baylor College of Medicine</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>Department of Pediatrics</gtr:department><gtr:description>Primary Human Medulloblastoma Cells</gtr:description><gtr:id>CB78B0A2-C84F-48CC-9EB8-0BD27EF85295</gtr:id><gtr:impact>As an early outcome, our collaborator have provided us with primary human medulloblastoma cells which are crucial for the progress of our project.</gtr:impact><gtr:outcomeId>VURW1JpT3au-1</gtr:outcomeId><gtr:partnerContribution>Our collaborators have provided us primary human cancer cells which are crucial for our project.</gtr:partnerContribution><gtr:piContribution>We have contributed the hypothesis to be tested and we have designed the experimental plan. We have established experimental methods to carry forward the project.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>European Institute of Oncology (IEO)</gtr:collaboratingOrganisation><gtr:country>Italy, Italian Republic</gtr:country><gtr:description>c-Myc dataset</gtr:description><gtr:id>8FDD706B-A08E-4E69-BFFD-A1A72519A67B</gtr:id><gtr:impact>The project is still on going and there are no outputs yet, but the results are expected to be submitted for publication in 2016.</gtr:impact><gtr:outcomeId>56d97d597f77e3.78626913-1</gtr:outcomeId><gtr:partnerContribution>They have helped in comparison of our gene signature with their ChIPSeq/RNASeq data.</gtr:partnerContribution><gtr:piContribution>We identified a gene signature in human choroid plexus tumours expressing high levels of cMyc</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Queen Mary University of London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Barts and The London School of Medicine and Dentistry</gtr:department><gtr:description>Bioinformatics for transcriptomic analysis</gtr:description><gtr:id>1DF44F33-1EB8-4AA6-9CE7-A651988127FF</gtr:id><gtr:impact>No output so far, data generation stage</gtr:impact><gtr:outcomeId>ZWQyqn9wWJx-1</gtr:outcomeId><gtr:partnerContribution>Provides bioinformatics support for the transcriptomic analysis included in our project.</gtr:partnerContribution><gtr:piContribution>Project design and establishment of the experimental methods to carry out the project</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Queen Mary University of London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Centre for Molecular Oncology</gtr:department><gtr:description>Temozolomide resistant glioblastoma project</gtr:description><gtr:id>9AF9565C-1301-481F-B219-7D55B4D7D4E1</gtr:id><gtr:impact>There are no outputs from this collaboration yet, but we are expecting to prepare and submit the manuscript by early 2014.</gtr:impact><gtr:outcomeId>DWBmWe9LpLc-1</gtr:outcomeId><gtr:partnerContribution>Our partners are conceiving this project and performing majority of the experiments and data collection.</gtr:partnerContribution><gtr:piContribution>We have contributed in generation of intracranial xenografts for in vivo mouse model. My supervisor and I would be examining the tissue specimens and providing professional opinion on histopathology diagnosis.</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Ludwig Maximilian University of Munich (LMU Munich)</gtr:collaboratingOrganisation><gtr:country>Germany, Federal Republic of</gtr:country><gtr:department>Centre for Neuropathology and Prion Research (ZNP)</gtr:department><gtr:description>Preclinical model of medulloblastoma</gtr:description><gtr:id>43B1C79E-F00E-414B-8F9D-875464A62FB5</gtr:id><gtr:impact>The project is in progress.</gtr:impact><gtr:outcomeId>qvSq6XQyA33-1</gtr:outcomeId><gtr:partnerContribution>Provide genetically engineered mouse model for validation of our findings on human primary medulloblastoma cells and xenografts</gtr:partnerContribution><gtr:piContribution>Develop original research question on primary cell culture of human medulloblastoma and on a xenograft model to be validated on a genetically engineered mouse model</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Hospital for Sick Children, Toronto</gtr:collaboratingOrganisation><gtr:country>Canada</gtr:country><gtr:department>Department of Neurosurgery</gtr:department><gtr:description>Correlation mouse/human medulloblastoma findings</gtr:description><gtr:id>E806BFB7-3F2A-44D0-89B5-761044B9CF49</gtr:id><gtr:impact>No output yet.</gtr:impact><gtr:outcomeId>AVbq7ayL4cb-1</gtr:outcomeId><gtr:partnerContribution>Analysis of correlations with human datsets</gtr:partnerContribution><gtr:piContribution>Develop original research data on mouse models</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Centre of the Cell 2016</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>8F3C4C9F-4527-4B7B-A20D-A50CBED427FD</gtr:id><gtr:impact>I was involved with facilitation of centre of the cell activity at the Blizard Institute of Queen Mary University of London, where school pupils are educated about biological sciences and institute's research is showcased. The activity brought about enthusiasm in medical/biological science and research among the attendees.</gtr:impact><gtr:outcomeId>56d9802329e707.40556766</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>National Pathology Week</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>B2110B3D-3FE9-4EDC-B68A-8FCC8B7ACE15</gtr:id><gtr:impact>More than 20 school students attended the event. They were very keen to be educated further.

The event was successful and well recieved. Further similar events requested.</gtr:impact><gtr:outcomeId>NX4NosPt4B2</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Facilitation of Centre of the Cell Activity</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>22D23FAE-8C2C-476A-BA0D-D218C17E6CB7</gtr:id><gtr:impact>I was involved in three separate workshops in 2013, involving about 60 students altogether. Several students were motivated in science and asked keen questions after the show.

There is an increasing interest for schools to visit Centre of the Cell.</gtr:impact><gtr:outcomeId>B7ZSLLouho3</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>Workshop Facilitator</gtr:presentationType><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:url>http://www.centreofthecell.org/index.php</gtr:url><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>BNS Academic Discussion Forum</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>57D7F5AF-83F7-4BEE-A809-5E2B953DAFC7</gtr:id><gtr:impact>I was involved in organising an 'academic discussion' workshop session for national neuropathology trainees. This is to encourage neuropathology trainees (junior doctors training in neuropathology specialty), to be trainees and post graduate students to involve in research and academic activities. This session was also designed to support those who are already involved in research and those who are planning to set up new research projects. This first session was chaired by Dr Tom Jacques and Prof Silvia Marino. 
The session saw active participation from all attendees and there was an increased interest in academia generated.</gtr:impact><gtr:outcomeId>58c6981fbd9723.48815070</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:url>http://www.bns.org.uk/</gtr:url><gtr:year>2017</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>RCPath workshop</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>9E607FE2-088F-4027-B945-ABA1AF2B6462</gtr:id><gtr:impact>This workshop is centred around discussion exploring the views of young people on different aspects of the new Human Tissue Act 2004. There was a keen participation by the audience. They felt they were educated and informed by this workshop.</gtr:impact><gtr:outcomeId>56d983a6c0de62.53611659</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>https://www.rcpath.org/event/your-body-your-consent.html</gtr:url><gtr:year>2015,2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Launch of Brain Tumour Research Excellence Centre</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>9CE99CA8-BD7E-4267-A15B-3429640B97E8</gtr:id><gtr:impact>About 60 people attended the launch event among whom were brain tumour patients, carers and family, charity trustees, politicians and media personnel. There was a very good response to the tour of the lab and presentations given and generated active discussion during and after the event.

There was an increase in interest for fundraising and support from the public and politician.</gtr:impact><gtr:outcomeId>54568fb6caf708.03831820</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:url>http://my.qmul.ac.uk/news_and_events/2014/141951.html</gtr:url><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>ATP training</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>5F174EA8-1FEC-4C8A-A36D-E47CDD8A8F62</gtr:id><gtr:impact>10-15 trainee mortuary techniticians attended the training session.

The students were very pleased with the new knowledge.</gtr:impact><gtr:outcomeId>DhehXPXJ7o6</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2010,2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>National Pathology Year 2012</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>202F32E2-7870-45FE-ADFC-F2E0E949F408</gtr:id><gtr:impact>I will be participating in the National Pathology Year 2012 event 'Promoting Pathology' (Organiser - Sarah Pitkin) to be held on 29th November 2012 at The Royal London Hospital. I look forward to this event which is aimed at generating pathology awareness to the general public and hospital staff.

To be held on 29th November 2012</gtr:impact><gtr:outcomeId>qmSb48XXwNp</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>Workshop Facilitator</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Article on Academic Training</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>F956556F-E98C-489D-A56F-405BFBDA8BA1</gtr:id><gtr:impact>In Summer 2012, article titled 'Pipettes, PCR, Proteins and More. Academic Training: Is This for You?' was published in Association of Clinical Pathologists (ACP) news bulletin, trainees' zone. I have also attempted to encourage the readers to develop an interest in academic/research training.

A positive feedback from the editor the ACP news bulletin regarding this article.</gtr:impact><gtr:outcomeId>GJjF27BgWEx</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>British Neuro-Oncology Society</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>CB7215EB-ACD3-4C41-BE77-676D090A189C</gtr:id><gtr:impact>I presented my research data as an oral poster presentation at British Neuro-Oncological Society (BNOS) Conference, held in Cambridge, 29 June - 01 July 2011.
My presentation was awarded best oral poster presentation. I was asked to write a brief article for the BNOS Newsletter which was published in August 2011 (Number 05/11).

This has helped for members of BNOS to learn about research activities in neuroscience. It has also helped me to learn about BNOS and to consider applying for BNOS membership.</gtr:impact><gtr:outcomeId>VVRhd8yEC7Y</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Poster Presentation</gtr:presentationType><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>STEM Ambassador</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>3E28D905-56D7-43A2-B7AE-5AB09786AF4B</gtr:id><gtr:impact>At Barts and the London School of Medicine and Dentistry, we have an established educational charity - 'Centre of the Cell' aimed for school students and general public. There is a state of the art 'Pod' which offers fun filled interactive way of learning science to the visitors. As a STEM ambassador, I have been involved in demonstration of the Pod sessions. I mainly demonstrate histopathology slides and gross specimens, explaining the pathology of diseases and answer any questions


At then end of the sessions the students express their gratitude for having learnt more about science. They are more aware of the career opportunities as scientists and researchers.</gtr:impact><gtr:outcomeId>Mc1oE1w8iw6</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>Workshop Facilitator</gtr:presentationType><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:url>http://www.stemnet.org.uk</gtr:url><gtr:year>2012</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>4764</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>BNS Small Grants Scheme</gtr:description><gtr:fundingOrg>British Neuropathological Society</gtr:fundingOrg><gtr:id>408416E9-0CE0-4657-BAE3-7326A2D93F5B</gtr:id><gtr:outcomeId>MEMwbudXwrk</gtr:outcomeId><gtr:sector>Learned Society</gtr:sector><gtr:start>2013-11-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Academic Clinical Lecturership</gtr:description><gtr:end>2018-07-02</gtr:end><gtr:fundingOrg>National Institute for Health Research</gtr:fundingOrg><gtr:id>0F33BCE5-10F3-4F6C-806E-FBE98A55730E</gtr:id><gtr:outcomeId>545684588988a8.73577884</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2014-07-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>218</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Travel and Conference Bursary</gtr:description><gtr:end>2012-02-02</gtr:end><gtr:fundingOrg>Pathological Society of Great Britain &amp; Ireland</gtr:fundingOrg><gtr:fundingRef>T&amp;CB 2011 05</gtr:fundingRef><gtr:id>6E887CEB-860E-44D8-82C0-0459FA098ADE</gtr:id><gtr:outcomeId>QiZNDCgJVRX</gtr:outcomeId><gtr:sector>Learned Society</gtr:sector><gtr:start>2011-12-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>550</gtr:amountPounds><gtr:country>Italy, Italian Republic</gtr:country><gtr:currCode>EUR</gtr:currCode><gtr:currCountryCode>Austria</gtr:currCountryCode><gtr:currLang>de_AT</gtr:currLang><gtr:description>Euro-CNS Travel Grant</gtr:description><gtr:end>2015-11-02</gtr:end><gtr:fundingOrg>European Confederation of Neuropathological Societies</gtr:fundingOrg><gtr:id>C90D9823-9D01-4EE7-85FB-F30D387D56C0</gtr:id><gtr:outcomeId>56cc67bf6cbd50.10429246</gtr:outcomeId><gtr:sector>Learned Society</gtr:sector><gtr:start>2015-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>10000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Pathological Society Small Grants Scheme</gtr:description><gtr:fundingOrg>Pathological Society of Great Britain &amp; Ireland</gtr:fundingOrg><gtr:fundingRef>SGS2013/04/03</gtr:fundingRef><gtr:id>5E75132B-64CF-45FD-8027-6F09AC3FCB4C</gtr:id><gtr:outcomeId>de3FD6Q8TCT</gtr:outcomeId><gtr:sector>Learned Society</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>8000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Barts Cancer Research Fund</gtr:description><gtr:fundingOrg>Barts Charity</gtr:fundingOrg><gtr:fundingRef>527/2087</gtr:fundingRef><gtr:id>20B2BC89-2E7F-4A77-871B-FAD5E77C7C27</gtr:id><gtr:outcomeId>XdGTwmwYrzT</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>5BADAD0C-4739-46E2-B062-EE574133A209</gtr:id><gtr:title>Venous infarction mimicking a neoplasm in spontaneous intracranial hypotension: an unusual cause of Parinaud's syndrome.</gtr:title><gtr:parentPublicationTitle>Journal of surgical case reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a11f2b9a22d37d130ed8d9c5205b100e"><gtr:id>a11f2b9a22d37d130ed8d9c5205b100e</gtr:id><gtr:otherNames>Bray TJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2042-8812</gtr:issn><gtr:outcomeId>58c12aa775dd27.15789478</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BDE33B6A-D053-44EE-9104-83578F4895A9</gtr:id><gtr:title>Bmi1 controls medulloblastoma invasion through inhibition of BMP-mediated cell adhesion</gtr:title><gtr:parentPublicationTitle>NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0eebfaae634daabd4d608234d88fcad8"><gtr:id>0eebfaae634daabd4d608234d88fcad8</gtr:id><gtr:otherNames>Merve A.</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0305-1846</gtr:issn><gtr:outcomeId>NxDSGF61e15</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C368A0E1-31CA-4F77-A0F8-3E364DAEE1CB</gtr:id><gtr:title>HICKAM'S DICTUM VERSUS OCKHAM'S RAZOR</gtr:title><gtr:parentPublicationTitle>Journal of Neurology, Neurosurgery &amp; Psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4be646430870ffacc5146bc933be85a9"><gtr:id>4be646430870ffacc5146bc933be85a9</gtr:id><gtr:otherNames>Marchant R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0022-3050</gtr:issn><gtr:outcomeId>58c12bd090c202.54183712</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>87D5EF67-F5C1-46FE-9600-BF2DB17CF4B9</gtr:id><gtr:title>BMI-1 GENE SILENCING INFLUENCES CELL ADHESION AND INVASIVE PROPERTIES OF MEDULLOBLASTOMA CELLS VIA INHIBITION OF BMP PATHWAY</gtr:title><gtr:parentPublicationTitle>NEURO-ONCOLOGY</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0eebfaae634daabd4d608234d88fcad8"><gtr:id>0eebfaae634daabd4d608234d88fcad8</gtr:id><gtr:otherNames>Merve A.</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1522-8517</gtr:issn><gtr:outcomeId>56d976be7c4319.57888357</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2C2CFF33-E644-4E0D-AAB9-BFDD668FE640</gtr:id><gtr:title>Lack of prognostic effect of carbonic anhydrase-9, hypoxia inducible factor-1a and bcl-2 in 286 patients with early squamous cell carcinoma of the glottic larynx treated with radiotherapy.</gtr:title><gtr:parentPublicationTitle>Clinical oncology (Royal College of Radiologists (Great Britain))</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/49014d014cbb11e4d03141dcf41e2aee"><gtr:id>49014d014cbb11e4d03141dcf41e2aee</gtr:id><gtr:otherNames>Douglas CM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0936-6555</gtr:issn><gtr:outcomeId>pm_13009_29_22841149</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>535DD5DB-BC46-441B-8F7D-51A0EADE59B5</gtr:id><gtr:title>Isolated pituitary IgG4-related autoimmune disease (IgG4-RD hypophysitis): A rare entity</gtr:title><gtr:parentPublicationTitle>NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0eebfaae634daabd4d608234d88fcad8"><gtr:id>0eebfaae634daabd4d608234d88fcad8</gtr:id><gtr:otherNames>Merve A.</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0305-1846</gtr:issn><gtr:outcomeId>56d9762c49c624.53601135</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A5BB881C-2EA0-4237-B3AC-E2D574BFE1D7</gtr:id><gtr:title>Polycomb group gene BMI1 controls invasion of medulloblastoma cells and inhibits BMP-regulated cell adhesion</gtr:title><gtr:parentPublicationTitle>NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0eebfaae634daabd4d608234d88fcad8"><gtr:id>0eebfaae634daabd4d608234d88fcad8</gtr:id><gtr:otherNames>Merve A.</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0305-1846</gtr:issn><gtr:outcomeId>56d976beb9a2a2.34728700</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FBAE0AA0-173C-4304-B3FF-0EF86CE00F07</gtr:id><gtr:title>CD8+ encephalitis: a severe but treatable HIV-related acute encephalopathy.</gtr:title><gtr:parentPublicationTitle>Practical neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/81a4d9c147d46c88cf058ba4d552b96b"><gtr:id>81a4d9c147d46c88cf058ba4d552b96b</gtr:id><gtr:otherNames>Zarkali A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1474-7758</gtr:issn><gtr:outcomeId>58c12aa705a3f9.25567326</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4028643E-7CE6-413A-86C0-B783EF0B8F69</gtr:id><gtr:title>Ectopic liver tissue in the kidney: case report and literature review.</gtr:title><gtr:parentPublicationTitle>Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9d1da85a7d0adbe10822422856d632f8"><gtr:id>9d1da85a7d0adbe10822422856d632f8</gtr:id><gtr:otherNames>Merve A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1093-5266</gtr:issn><gtr:outcomeId>54567b3f422ab4.73528737</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>10A78555-1940-435A-A8BD-58AC392F3F25</gtr:id><gtr:title>MASS ON SCAN OR MASSON SCAN</gtr:title><gtr:parentPublicationTitle>Journal of Neurology, Neurosurgery &amp; Psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/da97902f59c16251064d47cc1c0dba20"><gtr:id>da97902f59c16251064d47cc1c0dba20</gtr:id><gtr:otherNames>Barritt A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0022-3050</gtr:issn><gtr:outcomeId>58c12bd0520663.51401808</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>636F432F-B464-4A74-A0DF-CB3DBA87A8CE</gtr:id><gtr:title>Prospective technical validation and assessment of intra-tumour heterogeneity of a low density array hypoxia gene profile in head and neck squamous cell carcinoma.</gtr:title><gtr:parentPublicationTitle>European journal of cancer (Oxford, England : 1990)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bda5a8e995cf5d8f588ca3df103b4336"><gtr:id>bda5a8e995cf5d8f588ca3df103b4336</gtr:id><gtr:otherNames>Betts GN</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0959-8049</gtr:issn><gtr:outcomeId>pm_13009_29_22951015</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FCEDB7FE-76EC-464D-90A4-AFFE7424CB74</gtr:id><gtr:title>c-Myc is expressed in a proportion of human choroid plexus tumours and its overexpression in the developing mouse CNS induces choroid plexus tumorigenesis</gtr:title><gtr:parentPublicationTitle>NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0eebfaae634daabd4d608234d88fcad8"><gtr:id>0eebfaae634daabd4d608234d88fcad8</gtr:id><gtr:otherNames>Merve A.</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0305-1846</gtr:issn><gtr:outcomeId>56d975bc7fccc0.08263362</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D09F5DDB-B248-4292-BF8B-F17E5FBF2899</gtr:id><gtr:title>Bmi1 controls medulloblastoma invasion through inhibition of BMP-mediated cell adhesion</gtr:title><gtr:parentPublicationTitle>NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0eebfaae634daabd4d608234d88fcad8"><gtr:id>0eebfaae634daabd4d608234d88fcad8</gtr:id><gtr:otherNames>Merve A.</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0305-1846</gtr:issn><gtr:outcomeId>PPpdWYbBW4a</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>593797C5-9B2F-4963-932A-CA449305C067</gtr:id><gtr:title>c-Myc in choroid plexus tumourigenesis</gtr:title><gtr:parentPublicationTitle>NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0eebfaae634daabd4d608234d88fcad8"><gtr:id>0eebfaae634daabd4d608234d88fcad8</gtr:id><gtr:otherNames>Merve A.</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0305-1846</gtr:issn><gtr:outcomeId>58c12b1e96d1e6.94568111</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D28B07AD-70DD-4ED9-9E9C-A48E1E8BF10F</gtr:id><gtr:title>OP10 * ROLE OF C-MYC IN CHOROID PLEXUS TUMOURS</gtr:title><gtr:parentPublicationTitle>Neuro-Oncology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9d1da85a7d0adbe10822422856d632f8"><gtr:id>9d1da85a7d0adbe10822422856d632f8</gtr:id><gtr:otherNames>Merve A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:outcomeId>54567d2340b688.55613508</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7516A668-0CEA-456E-8E6D-463A1B9DBA5F</gtr:id><gtr:title>Polycomb group gene BMI1 controls invasion of medulloblastoma cells and inhibits BMP-regulated cell adhesion.</gtr:title><gtr:parentPublicationTitle>Acta neuropathologica communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9d1da85a7d0adbe10822422856d632f8"><gtr:id>9d1da85a7d0adbe10822422856d632f8</gtr:id><gtr:otherNames>Merve A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>2051-5960</gtr:issn><gtr:outcomeId>54567b3f18fb11.31475426</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7A806045-EB5D-4F56-91DE-B0F987E35AEF</gtr:id><gtr:title>Drug-Repositioning Screens Identify Triamterene as a Selective Drug for the Treatment of DNA Mismatch Repair Deficient Cells.</gtr:title><gtr:parentPublicationTitle>Clinical cancer research : an official journal of the American Association for Cancer Research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0b1b24a187dfbc8fce8f94d8cd01b870"><gtr:id>0b1b24a187dfbc8fce8f94d8cd01b870</gtr:id><gtr:otherNames>Guillotin D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1078-0432</gtr:issn><gtr:outcomeId>58c12aa73c52d2.97818953</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A6FEFFD9-AD56-41DF-9291-E3D5B18BDA59</gtr:id><gtr:title>ROLE OF C-MYC IN CHOROID PLEXUS TUMOURS</gtr:title><gtr:parentPublicationTitle>NEURO-ONCOLOGY</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a7087a3eebb18865076f6ae3933679aa"><gtr:id>a7087a3eebb18865076f6ae3933679aa</gtr:id><gtr:otherNames>Merve Ashirwad</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1522-8517</gtr:issn><gtr:outcomeId>58c12b1ee21ea8.26762409</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>47340C58-D0E4-438D-90AB-00F8F44BBC2B</gtr:id><gtr:title>Audit of Testicular Tumour Expert Histopathology Referrals</gtr:title><gtr:parentPublicationTitle>JOURNAL OF PATHOLOGY</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0eebfaae634daabd4d608234d88fcad8"><gtr:id>0eebfaae634daabd4d608234d88fcad8</gtr:id><gtr:otherNames>Merve A.</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0022-3417</gtr:issn><gtr:outcomeId>K9MSUkMNqTB</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0902001</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>7C58A707-1BF6-4573-A44F-30B271C80813</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Cancer</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>